Although IGF-1, adipocytokines, inflammation, and other obesity-related factors, as well as many cancers, have been individually associated with upregulation of TGF-β and other EMT pathway components,52–56 their combined interactions are poorly characterized. Here, IGF1 is linked to cancer.